Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada (Q79186097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Histology-related variation in the treatment and survival of patients with lung carcinoma in Canada (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(03)00283-6

23 March 2024

author name string

Lin Xie

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Anne-Marie Ugnat

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Judy Morriss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Robert Semenciw

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Yang Mao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14568680

23 March 2024

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 December 2019

https://api.elsevier.com/content/article/PII:S0169500203002836?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(03)00283-6

https://api.elsevier.com/content/article/PII:S0169500203002836?httpAccept=text/plain

23 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(03)00283-6

23 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

127-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors in lung cancer based on multivariate analysis

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Clinical factors and prognosis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

1 reference

7 January 2021

Prognosis of patients with lung cancer diagnosed in Norway, 1954-93.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Comparison between young and old patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Lung carcinoma in 1,336 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Determinants of long term survival after surgery for cancer of the lung: A population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Perceptions of prognosis, treatment, and treatment impact on prognosis in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Evidence-based medicine in the treatment of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Relative survival and the estimation of net survival: elements for further discussion.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Surgical therapy of early non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

The Curative Treatment by Radiotherapy Alone of Stage I Non-Small Cell Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Neoadjuvant therapy and surgical resection for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Locally advanced, unresectable non-small cell lung cancer: new treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Treatment of stage II lung cancer (T1N1 and T2N1).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

The National Cancer Data Base report on lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900283-6

7 January 2021

The relative survival rate: a statistical methodology

18

1 reference

https://api.crossref.org/works/10.1016/S0169-5002(03)00283-6

23 March 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568680%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference